
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy is an official journal of @ACCP.
Lenexa, KS
Joined September 2015
- Tweets3.7K
- Following282
- Followers11.9K
- Likes3.1K
Congratulations to ACCP member Cameron J. McKinzie and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/9OOP50YO30n
#MakingAnImpact #ACCP @PharmacoJournal
Congratulations to ACCP member Cyrille K. Cornelio and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/jMlQ50YO3cE
#MakingAnImpact #ACCP @PharmacoJournal
Pharmacotherapy retweeted
🔥 Just published 🔥 @PharmacoJournal
Focused Update to International Consensus Recommendations for the Use of Prolonged-Infusion Beta-Lactam Antibiotics Among Severely Ill Adult Patients
Led by Lisa Hong 🌟
Endorsed by:
@ACCP @BSACandJAC @IDSAInfo @ESCMID @SCCM @CF_Foundation @SIDPharm
#IDXposts
EnJoy
accpjournals.onlinelibrary.w…
🤖 Made with AI
Congratulations to ACCP member Erin F. Barreto and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/2nOC50Z4heZ
#MakingAnImpact #ACCP @PharmacoJournal
Congratulations to ACCP member Milre M. Matherne and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/RfCj50Z4hJx
#MakingAnImpact #ACCP @PharmacoJournal
Congratulations to ACCP member Xinyi Huang and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/XEyu50Z4hxp
#MakingAnImpact #ACCP @PharmacoJournal
Congratulations to ACCP member Alejandro D. Perez and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/CkT950Z4igO
#MakingAnImpact #ACCP @PharmacoJournal
Congratulations to ACCP member Raechel T. White and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/ae6w50Z4iGN
#MakingAnImpact #ACCP @PharmacoJournal
Pharmacotherapy retweeted
En @PharmacoJournal CONSENSO multidisciplinar @IDSAInfo 🇺🇸🩺,@ESCMID 🇪🇺🩺🧫,@accpinfdprn🇺🇸💊…en INFUSIÓN EXTENDIDA (continúa o >3 horas)de #Blactamicos en PACIENTES #GRAVES🛌
Beneficio suma 28 ens. clínicos 🆚intermitente🟰DISMINUCION mortalidad📉☠️
🔗 🆓 accpjournals.onlinelibrary.w…
Congratulations to ACCP member Christie Schumacher and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/fg8850ZeaZb
#MakingAnImpact #ACCP @PharmacoJournal
Congratulations to ACCP member Susan E. Smith and co-authors on the recent publication of their article in Pharmacotherapy! Access the abstract and/or article here: ow.ly/tSFc50Zeb1x
#MakingAnImpact #ACCP #OpenAccess @PharmacoJournal
The goal of this themed issue is to report recent advances in lipid-lowering pharmacotherapy, pharmacoepidemiology, risk assessment and stratification, and pharmacovigilance of dyslipidemia that positively impact cardiovascular health. buff.ly/thlYv57
The authors suggest prolonged infusion for severely ill patients for both mortality and clinical cure reasons. An absolute mortality reduction of 2% corresponds to a number-needed-to-treat of 50 to prevent one death. OPEN ACCESS: buff.ly/GnUmMCc
A 22-person, interprofessional author panel, led by @erin_barreto and @njrhodes_rx systematically evaluated the literature to address beta-lactam dose individualization buff.ly/ficI4MK @ACCP @ESCMID @IDSAInfo @IATDMCT @SCCM @SIDPharm
In the cohort of patients receiving concurrent propofol and clevidipine, the frequency of hypertriglyceridemia and acute pancreatitis was low. buff.ly/S79crYr
This review distinguishes phenobarbital-first, protocolized ICU pathways from adjunctive or mixed phenobarbital strategies, suggesting that implementation design may influence outcomes. buff.ly/CVZFRLw
GLP-1 RAs were associated with a decreased risk of asthma exacerbation compared to SGLT-2is among patients with asthma and type 2 diabetes. buff.ly/wRTkDoZ
Fosmanogepix is an investigational antifungal with a novel mechanism of action and has shown broad in vitro activity. Early clinical trials suggest a manageable adverse effect profile, making it an attractive treatment option. buff.ly/Qwc9NVQ
International collaboration in scientific discovery encourages the sharing of resources, ideas, and expertise. Benefits include an accelerated pace of scientific progress that may allow social and economic gains for multiple nations. buff.ly/WM8VIU0
Drs. Shannon Finks and Sarah McBane discuss their July 2026 narrative review, “Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.” buff.ly/afKW0jF






















